Provided by Tiger Trade Technology Pte. Ltd.

OCUMENSION-B

6.940
-0.050-0.72%
Volume:359.50K
Turnover:2.49M
Market Cap:5.66B
PE:-17.69
High:7.030
Open:7.010
Low:6.850
Close:6.990
52wk High:12.230
52wk Low:3.910
Shares:815.00M
HK Float Shares:815.00M
Volume Ratio:0.31
T/O Rate:0.04%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.392
ROE:-7.76%
ROA:-5.07%
PB:1.37
PE(LYR):-17.69
PS:9.17

Loading ...

China Post Securities: AI Emerges as "Acceleration Engine" for New Drug Discovery, Recommends Focus on AI4S and AI+Pharmaceutical Sectors

Stock News
·
Jan 15

Hong Kong Stock Anomaly | Ascletis Pharma-B (01672) Surges Over 6% in Afternoon Trading on Strong ASC30 Data, Company Raises Buyback Cap to HK$500 Million

Stock News
·
Jan 14

Zhong Sheng Pharmaceutical Surges Over 4% in Early Trading, Plans 12 Billion Yuan Acquisition of Hejiya Biotech

Deep News
·
Jan 14

Pharma Giants Shed Uncertainty: 2025 M&A Soars 124%, Big Players Gobble Up Innovative Drug Assets

Stock News
·
Jan 09

New Listing News | Mingyu Pharmaceutical Plans Hong Kong IPO, China Securities Regulatory Commission Requests Additional Details on Equity Structure and Round-trip M&A Compliance

Stock News
·
Jan 09

Betta Pharmaceuticals (300558.SZ) Invests 50 Million Yuan in Zhixing Pharmaceutical, a Company Focused on Advanced Inhalation Formulations

Stock News
·
Jan 09

$100 Billion "Patent Cliff" Looms! U.S. Pharma Giants Target New Drug Acquisitions, Are Small-Cap Biotech Stocks Set for a "Super Premium" Investment Feast?

Stock News
·
Jan 09

Hainan Poly Pharm Appeals Against Investor Victory in Landmark Compensation Case

Deep News
·
Jan 09

Hisamitsu's Stock Soars 38% in Two Days! Capital Floods into Japan's Undervalued Pharma Firms, Betting on Privatization Wave

Stock News
·
Jan 08

Breakeven Is Near for Ocumension Therapeutics (HKG:1477)

Simply Wall St.
·
Jan 08

Yifan Pharmaceutical (002019.SZ) Subsidiary Signs Exclusive Agreement for an Innovative Drug

Stock News
·
Jan 05

Insilico Medicine (03696), HKEX's "AI Pharma Pioneer," Strikes $888 Million Partnership with Global Giant, Firing First Shot in 2026 Biopharma BD

Stock News
·
Jan 05

ASCLETIS-B (01672) Announces FDA Approval of IND for 13-Week Phase II Study of ASC30 in Diabetic Subjects

Stock News
·
Jan 05

Hong Kong Stocks Movement | XTALPI (02228) Surges Over 8% in Early Trading as Business Extends from AI Drug Discovery to AI4S Platform

Stock News
·
Jan 02

Ascletis-B (01672) Repurchases 200,000 Shares for HK$2.4829 Million on December 29

Stock News
·
Dec 29, 2025

Orient Securities Initiates Coverage on Ascletis Pharma-B (01672) with "Buy" Rating, Sets Target Price at HK$18.38

Stock News
·
Dec 29, 2025

IPO News: LuPeng Pharmaceutical Plans Hong Kong Listing; CSRC Requests Supplementary Details on Offshore Structure Compliance and Round-Trip M&A

Stock News
·
Dec 26, 2025

Investors Win Lawsuit Against *ST Poly (300630), New Claims Filed Against Hainan Huatie (603300)

Deep News
·
Dec 25, 2025

FDA Expands Indication for Blood Disorder Drug, ACADIA Pharmaceuticals' Stock Soars

Deep News
·
Dec 24, 2025

Leadership Transition at Pharmaceutical Giant: The Real Story Behind the Change

Deep News
·
Dec 24, 2025